← All trials

NCT07214298

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Dec 1, 2025
Primary completion
Oct 1, 2027
Completion date
Oct 1, 2028
First posted
Oct 9, 2025
Last posted
Nov 14, 2025
Enrollment
35
Arms / groups
1 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.